$AGLY
Atlantis Glory Inc.

2024 Q1 Form 10-K Financial Statement

#000149315224009763 Filed on March 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $9.005K $68.03K
YoY Change -74.67% 9.19%
Operating Profit -$68.03K
YoY Change 9.19%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$9.005K -$68.03K
YoY Change -74.67% -100.82%
Income Tax
% Of Pretax Income
Net Earnings -$9.005K -$68.03K
YoY Change -74.67% -100.82%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 604.0M shares 604.0M shares 604.0M shares
Diluted Shares Outstanding 604.0M shares 604.0M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets $0.00
Total Assets
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $140.0K $130.9K
YoY Change 42.12% 82.07%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $140.0K $130.9K
Total Long-Term Liabilities
Total Liabilities $140.0K $130.9K
YoY Change 42.12% 82.07%
SHAREHOLDERS EQUITY
Retained Earnings -$1.076M -$1.067M
YoY Change 4.01% 6.81%
Common Stock $604.0K $604.0K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$140.0K -$130.9K
YoY Change
Total Liabilities & Shareholders Equity
YoY Change

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$9.005K -$68.03K
YoY Change -74.67% -100.82%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$13.01K -$55.58K
YoY Change -51.75% -14.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $13.01K $55.58K
YoY Change -51.75% -14.46%
NET CHANGE
Cash From Operating Activities -$13.01K -$55.58K
Cash From Investing Activities
Cash From Financing Activities $13.01K $55.58K
Net Change In Cash $0.00 $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$13.01K -$55.58K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001673504
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
usd
CY2023Q4 us-gaap Assets
Assets
usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2023 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations
usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity Registrant Name
EntityRegistrantName
ATLANTIS GLORY INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity File Number
EntityFileNumber
333-213608
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-3995730
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
Room 2106
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Beautiful Group Tower
CY2023 dei Entity Address Address Line3
EntityAddressAddressLine3
77 Connaught Road Central
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Hong Kong
CY2023 dei Entity Address Country
EntityAddressCountry
HK
CY2023 dei City Area Code
CityAreaCode
852
CY2023 dei Local Phone Number
LocalPhoneNumber
4620 9298
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 dei Entity Public Float
EntityPublicFloat
336917500 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
603970000 shares
CY2023 dei Auditor Name
AuditorName
JP Centurion & Partners PLT
CY2023 dei Auditor Location
AuditorLocation
Kuala Lumpur, Malaysia
CY2023 dei Auditor Firm
AuditorFirmId
6723
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
9000 usd
CY2022Q4 us-gaap Assets
Assets
9000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
10400 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
6950 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
130949 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
71923 usd
CY2023Q4 us-gaap Liabilities
Liabilities
130949 usd
CY2022Q4 us-gaap Liabilities
Liabilities
71923 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000000 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
10000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
10000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
990000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
990000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
603970000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
603970000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
603970 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
603970 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
321809 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
321809 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1066728 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-998702 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-130949 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-62923 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
68026 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
62301 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
68026 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
62301 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-68026 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-62301 usd
CY2022 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
8333679 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8333679 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-68026 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8271378 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-68026 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
8271378 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
603970000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
603970000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
603970000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
603970000 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-8334301 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
8271378 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-62923 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-62923 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-62923 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-68026 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-68026 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-130949 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-130949 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
990000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
990000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-68026 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
8271378 usd
CY2022 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
8333679 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-9000 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
9000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3450 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6328 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-55576 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-64973 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
55576 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
64973 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
55576 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64973 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_zrqpyFixSL27" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86F_zRNR3tJ1HTg6">Use of estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Management makes these estimates using the best information available at the time the estimates are made; however actual results could differ from those estimates. Significant items subject to such estimates and assumptions include valuation of inventory, and recoverability of carrying amount and the estimated useful lives of long-lived assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-68026 usd
CY2023Q4 AGLY Working Capital
WorkingCapital
-130949 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1066728 usd
CY2023Q4 us-gaap Liabilities
Liabilities
130949 usd
CY2022Q4 us-gaap Liabilities
Liabilities
71923 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
603970000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
603970000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
603970000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
603970000 shares
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
R10.htm Edgar Link pending
0001493152-24-009763-index-headers.html Edgar Link pending
0001493152-24-009763-index.html Edgar Link pending
0001493152-24-009763.txt Edgar Link pending
0001493152-24-009763-xbrl.zip Edgar Link pending
agly-20231231.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
agly-20231231_cal.xml Edgar Link unprocessable
agly-20231231_def.xml Edgar Link unprocessable
agly-20231231_lab.xml Edgar Link unprocessable
agly-20231231_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable